What Should Specialty Pharmacists Know About the REVERCE Clinical Trial?

Article
Conference|Gastrointestinal Cancers Symposium

Kohei Shitara, MD, Department of Gastrointestinal Oncology of National Cancer Center Hospital East, Japan, discusses the importance of the REVERCE clinical trial for specialty pharmacists.

Related Videos
Related Content
3d rendered illustration of lung cancer 3D illustration | Image Credit: appledesign - stock.adobe.com

Samsung Bioepis Initiates Phase 3 Clinical Trial for Proposed Pembrolizumab Biosimilar

April 22nd 2024
Article
Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

March 26th 2024
Podcast
Pharmacist gathering medication -- Image credit: Arnéll Koegelenberg/peopleimages.com | stock.adobe.com

The Fludarabine Shortage and Its Ripple Effects: Navigating the Crisis

April 22nd 2024
Article
Pharmacy Focus: Limited Series - Celebrity Endorsements in Pharmaceuticals

Pharmacy Focus: Limited Series - Celebrity Endorsements in Pharmaceuticals

February 28th 2024
Podcast
Lymphoma written on paper -- Image credit: tashatuvango | stock.adobe.com

Study Examining Glofitamab With GemOX in Patients With R/R DLBCL Meets Primary Endpoint

April 19th 2024
Article
Tumor in lungs -- Image credit: Sebastian Kaulitzki | stock.adobe.com

FDA Approves Alectinib to Treat Patients With ALK-Positive NSCLC

April 19th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.